Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation

Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA), a leader in cell programming and biosecurity, has scheduled its Q1 2025 earnings presentation for Tuesday, May 6, 2025, at 5:30 p.m. ET. The company will review its business performance for the quarter ended March 31, 2025.

The presentation will be accessible through Ginkgo's investor relations website at investors.ginkgobioworks.com, with a replay option available. Stakeholders can submit questions beforehand via:

• X (formerly Twitter) using @Ginkgo and #GinkgoResults
• Email at investors@ginkgobioworks.com

News Market Reaction – DNA

-0.14%

-0.14% Session move

In the trading session that priced this news, DNA declined 0.14%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Presentation and Q&A session scheduled for post-market on Tuesday, May 6, 2025

BOSTON, April 29, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business performance for the first quarter ended March 31, 2025, on Tuesday, May 6, 2025, beginning at 5:30 p.m. ET.

The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats.  For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:

investors@ginkgobioworks.com    

MEDIA CONTACT:

press@ginkgobioworks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-first-quarter-2025-results-presentation-302441429.html

SOURCE Ginkgo Bioworks

FAQ

When will Ginkgo Bioworks (DNA) release Q1 2025 earnings?

Ginkgo Bioworks (DNA) will release its Q1 2025 earnings on Tuesday, May 6, 2025, at 5:30 p.m. ET, after market close.

How can investors participate in Ginkgo Bioworks Q1 2025 earnings call?

Investors can access the webcast through Ginkgo's investor relations website at investors.ginkgobioworks.com. Questions can be submitted via X (using #GinkgoResults) or by emailing investors@ginkgobioworks.com.

What period does Ginkgo Bioworks (DNA) Q1 2025 earnings cover?

The earnings presentation will cover Ginkgo Bioworks' financial performance for the first quarter ended March 31, 2025.

Will there be a replay available for Ginkgo Bioworks Q1 2025 earnings call?

Yes, a replay of the earnings presentation and Q&A session will be made available on Ginkgo's investor relations website.

How can investors submit questions for Ginkgo Bioworks Q1 2025 earnings?

Investors can submit questions by either posting on X with the hashtag #GinkgoResults or by sending an email to investors@ginkgobioworks.com.